Rejuran offers a new class of bioregenerative science, powered by PharmaResearch’s proprietary DNA Optimization Technology (DOT) from South Korea. Through this advanced process, Rejuran delivers high-purity, clinically validated hydrolyzed DNA to restore, regenerate and strengthen skin at the cellular level. Formulated to integrate seamlessly with leading in-clinic procedures—including RF microneedling, microneedling, fractional laser, microdermabrasion and platforms such as Morpheus8, SylfirmX, Potenza, Clear + Brilliant, PicoSure and Q-Switch lasers—Rejuran enhances treatment outcomes while supporting long-term skin health. Its breakthrough hydrolyzed DNA technology improves microcirculation, activates collagen synthesis, reduces inflammation and promotes healthy cellular turnover, helping address the appearance of wrinkles, textural irregularities, dehydration, thinning skin and other visible signs of aging.